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The HPV Vaccination:
Necessary or Evil?
Pauline Self, R.N.*
I. INTRODUCTION
"Genital warts," "colposcopy," "cervical 'punch' biopsy," "Pap
smear" - these words, which could make even the most self-assured and
spirited women cringe,1 are all associated with cervical cancer. Cervical
cancer is the second most common cause of cancer-related deaths in
women worldwide.2 Within recent years, medical science has identified a
direct association between certain types of Human Papillomavirus (HPV), a
sexually transmitted disease that causes genital warts, and the development
of cervical cancer. According to the American Cancer Society, 99.7
percent of all cervical cancer cases are linked to HPV,3 which is highly
prevalent in sexually active men and women.4 Present-day figures indicate
that an estimated 80 percent of women under the age of fifty will contract
HPV.5 An increasing number of women are found to have abnormal Pap
smears, colposcopy exams and biopsies due to sexual relations with an
HPV-positive partner. Unfortunately, it is usually impossible to know
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1. Ann Dubay, HPV Vaccine is a Great Thing but Should it be Mandatory?, PRESS
DEMOCRAT, Feb. 18, 2007, at B 11.
2. Joeli Brinkman et al., The Impact of Anti HPV Vaccination on Cervical Cancer
Incidence and HPV Induced Lesions: Consequences for Clinical Management, 26(2) EUR. J.
GYNAECOLOGICAL ONCOLOGY, 129, 129 (2005), available at http://www.ncbi.nlm.nih.
gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch= 15857016&ordinal
pos=4&itool=EntrezSystem2.PEntrez.Pubmed.PubmedResultsPanel.PubmedRVDocSum.
3. Amy Paulin, HPV Vaccine Should be Added to the Mandatory List in New York
State, J. NEWS (Westchester County, N.Y.), June 11, 2007, at 4B.
4. David Soper, Reducing the Health Burden of HPV Infection Through Vaccination,
INFECTIOUS DISEASES OBSTETRICS & GYNECOLOGY (2006), http://www.pubmedcentral.
nih.gov/articlerender.fcgi?artid= 1522061.
5. DuBay, supra note 1.
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which person transmitted the disease. 6 Frequently, HPV is asymptomatic
until years later when several strains of the virus can cause precancerous
conditions that, if left undiagnosed and untreated, can lead to cervical
cancer.
7
Recently, an anti-viral HPV vaccine, Gardasil, was developed and has
the potential to significantly reduce the rate of HPV-associated cervical
cancer. Despite the apparent public health benefits of the HPV vaccine, the
desire of some lawmakers to mandate the vaccine for school girls has
placed it at the center of political, medical, and moral jousting throughout
the country. Legislators in at least forty-one states and Washington, D.C.
have introduced legislation to require, fund, or educate the public about the
HPV vaccine, and to date, at least seventeen states have enacted this
legislation.8 However, these various proposals, as well as a state bill signed
into law making the HPV vaccination a school requirement, have caused
great furor and debate between health care advocates who prefer aggressive
use of the injections for minors and social conservatives and parents who
feel that readily available vaccines will encourage sexual activity. This
Note will discuss the nation-wide impact of the HPV disease, United States
history regarding mandatory vaccination laws and the current exemptions
for mandatory vaccinations, arguments for and against mandating the HPV
vaccination for female minors, and an effective approach to the mandatory
vaccination issue. The solution, as the reader will see below, is anything
but clear.
II. BACKGROUND: SCIENTIFIC DATA REGARDING HPV
AND GARDASIL
"According to the Centers for Disease Control (CDC) and the
American College of Obstetrics and Gynecology, HPV consists of a group
of over 100 types of papillomaviruses." 9 They are called papillomaviruses
because certain types may cause warts or papillomas, which are benign
(noncancerous) tumors. 10 Of these viruses, about thirty strains infect the
genital area and can be transmitted through sexual contact" even if the
carriers are asymptomatic. 12 Research has shown that many women who
become infected with HPV will be asymptomatic and their infection will
6. DuBay, supra note 1.
7. Id.
8. NAT'L CONFERENCE OF STATE LEGISLATURES, HPV VACCINE (2007), http://www.
ncsl.org/programs/health/HPVvaccine.htm.
9. Camilla Herrera, The Facts About HPV, STAMFORD ADVOC. (Conn.), July 10,
2007, at B 1.
10. NAT'L CANCER INST., HUMAN PAPILLOMAVIRUSES AND CANCER- QUESTIONS &
ANSWERS, http://www.cancer.gov/cancertopics/factsheet/Risk/HPV (last visited Oct. 14,
2007).
11. Id.
12. Herrera, supra note 9.
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become undetectable within approximately two years. 13 However, some
strains of HPV are associated with certain types of cancer and are called
"high-risk" oncogenic (or cancer-associated) HPV. 14 Approximately 6.2
million new genital HPV infections occur each year in the United States.15
Accordingly, HPV has been referred to as the "common cold of sexually
transmitted diseases."'
16
The development of the HPV vaccine was based on the hypothesis that
exposure to HPV's unique surface components would result in a host
antibody response that would protect the body against infection. 17 Early
studies demonstrated that vaccination with these noninfectious virus-like
particles (VLP) resulted in the production of antibodies that prevented the
complete papillomavirus from infecting cells.18
The National Cancer Institute (NCI) has licensed two pharmaceutical
companies, Merck & Company (Merck) and GlaxoSmithKline (GSK), to
develop HPV vaccines for widespread distribution.1 9 On June 8, 2006, the
U.S. Food and Drug Administration (FDA) approved the Merck vaccine,
Gardasil.2 ° Another vaccine, Cervarix, produced and currently being tested
by GSK, awaits approval from the FDA.21 Gardasil has been shown to be
highly effective in preventing chronic infection by four of the most
22common HPV strains. These strains include two "high risk" HPV types
(16 and 18) that cause most (70 percent) cervical cancers, and types 6 and
11, which cause virtually all (90 percent) of genital warts.23
Gardasil is given through a series of three intramuscular injections over
a six-month period.24 According to the CDC, Gardasil has been tested on
more than 11,000 girls and women worldwide, with few adverse side
13. CENTERS FOR DISEASE CONTROL AND PREVENTION, GENITAL HPV INFECTION,
http://www.cdc.gov/std/HPV/STDFact-HPV.htm [hereinafter CDC] (last visited Aug. 7,
2007).
14. CDC, HPV AND HPV VACCINE - INFORMATION FOR HEALTH CARE PROVIDERS,
http://www.cdc.gov/std/hpv/STDFact-HPV-vaccine-hcp.htm (last visited Aug. 7, 2007).
15. Id. (citing Hillard Weinstock, Stuart Berman & Willard Cates Jr., Sexually
Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000,
36(1) PERSP. ON SEXUAL & REPROD. HEALTH, 6, 8 (2004)).
16. Jane Martin, Sure Shot, THE SUNDAY MAIL (AUSTRALIA), Apr. 29, 2007, at 4.
17. NAT'L CANCER INST., HUMAN PAPILLOMAVIRUS (HPV) VACCINES - QUESTIONS &
ANSWERS, http://www.cancer.gov/cancertopics/factsheet/risk/HPV-vaccine (last visited Oct.
30, 2007).
18. Id.
19. Id.
20. Cancer Vaccines; Data Published in the Lancet Show Gardasil was 100 Percent
Effective in Preventing High-Grade Vulvar and Vaginal Lesions Caused by HPV Types 16
and 18, PHYSICIANS L. WKLY., June 6, 2007, at 174 [hereinafter Cancer Vaccines].
21. NAT'L CANCER INST., supra note 17.
22. CDC, HPV VACCINE - QUESTIONS & ANSWERS, http://www.cdc.gov/vaccines/
vpd-vac/hpv/vac-faqs.htm (last visited Aug. 7, 2007).
23. Id.
24. Id.
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effects.25 Significantly, Gardasil is proven to be 100 percent effective for
up to four years after vaccination, but only if administered before infection
26
with HPV. 26 At the present time, the FDA has approved Gardasil for use in
females between nine and twenty-six years of age.27  Recent research
findings regarding Gardasil were published in the May 10, 2007, edition of
The New England Journal of Medicine. These findings involve three
additional years of follow-up study among 17,500 women, aged fifteen to
twenty-six, spread across several developed and developing countries.28 In
one study, Gardasil was 100 percent effective in preventing genital warts
and precancerous and cancerous lesions of the vulva, vagina, and cervix in
women who were not infected with any of the four targeted strains at the
time of vaccination. 29 However, in women who were previously infected
with any of the four targeted strains, other strains that cause HPV infection,
or both, the rate of lesions were reduced by 17 percent in one study and by
less than 35 percent in another study.30 These findings clearly demonstrate
that the vaccine's effectiveness is optimal before the onset of sexual
activity and confirm the need to provide the vaccine before exposure to the
targeted HPV strains.3 '
Studies thus far have shown that the vaccine has side effects similar to
those of many other vaccinations, i.e., mild to moderate local reactions
such as pain, erythema, swelling, and tenderness at the injection site.32 As
of February 21, 2007, approximately 500 cases of mostly minor side
effects, including dizziness, fever, and fainting, have been reported in girls
and women who received Gardasil. 33 The majority of these side effects,
however, occurred immediately after receiving the injection, and health
officials now recommend a fifteen minute period after the injection before
leaving the doctor's office in case of fainting or other problems.34 As of
February 2007, there have also been two reports of Guillian-Barre
syndrome (a more serious immunological response also seen with other
immunizations such as the (influenza) flu vaccine)35 following vaccinations
25. HPV Vaccine: Doctors Welcome It But Question Mandate of Anticancer Shot;
Human Papillomavirus, MED. ETHICS ADVISOR, May 1, 2007.
26. Cancer Vaccines, supra note 20.
27. CNN.com, No New Warnings Planned for Cervical Cancer Vaccine, Feb. 21,
2007 (on file with author).
28. New Cervical Cancer Vaccine Highly Promising, But Questions Remain,
HARVARD WOMEN'S HEALTH WATCH, Aug. 1, 2007.
29. Id.
30. Id.
31. Id.
32. Laura J. Grimshaw-Mulcahy, HPV Vaccination Fights Cervical Cancer,
NURSING SPECTRUM, July 30, 2007, at 16.
33. CNN.com, supra note 27.
34. Id.
35. NAT'L VACCINE INFO. CTR., HUMAN PAPILLOMA VIRUS VACCINE SAFETY, http://
www.909shot.com/Diseases/HPV/HPVrpt.htm (last visited Feb. 17, 2007).
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with Gardasil. 36 However, in both cases, the girls were also vaccinated
with Aventis Pasteur's Menactra, a vaccine for meningococcal infections
which has previously been associated with Guillain-Barre syndrome.37
Therefore, representatives from the immunization safety office at the
United States Centers for Diseases and Prevention do not believe that a
clear link exists between the vaccine and Guillain-Barre. 38 Currently, the
CDC continues to carefully monitor the vaccine's safety39 and government
health officials presently state that no additional warning labels are
needed.4°
When the World Health Organization (WHO) convened in 2003 to
discuss the HPV vaccine's effectiveness trials, the consensus was that if the
HPV vaccine proves to be effective against transient or persistent HPV
infections, it was likely that it would protect women against the
development of cervical cancer.4' Seven years later, after significant
research and clinical trials, the WHO's theory has proven true. The WHO
has also recognized that once the vaccine has been introduced into the
population, it will be some years before reduction in cervical cancer is
detectable at a national level.42 Therefore, they stressed the importance of
maintaining existing cervical screening programs while long-term studies
are conducted a3
III. HISTORY OF IMMUNIZATION LAWS
For generations, the arrival of a potent new vaccine against a killer
disease (such as the vaccine for polio in the 1950s) was reason for
widespread celebration. To this end, the sweeping reduction over the past
century in morbidity and mortality rates due to vaccine-preventable illness
is considered one of the most significant achievements of public health.44
The history of vaccination can be traced back to the early 1800s.45 In
1827, the city of Boston required vaccination for school attendance and, in
1855, Massachusetts became the first state to require childhood vaccination
36. NAT'L VACCINE INFO. CTR., supra note 35.
37. Id.
38. CNN.com, supra note 27.
39. Grimshaw-Mulcahy, supra note 32, at 16.
40. CNN.com, supra note 27.
41. S.R. Pagliusi & Teresa M. Aguado, Efficacy and Other Milestones for Human
Papillomavirus Vaccine Introduction, VACCINE, Dec. 16, 2004, at 568-87.
42. Id.
43. Id.
44. Ross D. Silverman, No More Kidding Around: Restructuring Non-Medical
Childhood Immunization Exemptions to Ensure Public Health Protection, 12 ANNALS
HEALTH L. 277, 277 (2003). See generally CDC, Achievements in Public Health, 1900-
1999, 48 MORBIDITY AND MORTALITY WKLY. REP. 621 (1999), available at
http://www.cdc.gov/mmwr/PDF/wk/mm4829.pdf.
45. BARRY R. FURROW ET. AL., HEALTH LAW: CASES, MATERIALS AND PROBLEMS 95
(5th ed. 2001).
as a precondition to school attendance.46 These laws were fairly common
by the end of the nineteenth century.4 7 For political and other social
reasons, however, they were not regularly enforced.48 In 1905, the United
States Supreme Court established the foundation for public health
regulations in the case of Jacobson v. Massachusetts.49 Jacobson created
the right of a state to compel an individual to be vaccinated. The Jacobson
Court held that the need to serve the "common good" confers upon states
broad powers that may restrain the rights of individuals. 50  At present,
courts. have determined that states and localities have the power to take
significant steps to protect children from communicable disease - even to
the extent of denying children the right to attend public school when not
vaccinated.
Throughout history, when asked to address the legal issue of whether
the government can compel vaccination, American courts have almost
always handed down decisions in support of mandatory immunizations. 1
Each state has individual immunization requirements, sometimes called
"school laws," that dictate what types of vaccinations must be given before
a child may enter school.52 In addition, federal laws specify the type of
information that must be given to parents before a child is immunized.53
Today, forty-seven states offer parents some form of religious exemption
from school immunization laws. 54 It was not until the mid-1970s, with the
introduction of the Child Abuse Prevention and Treatment Act of 1974,
that almost universal execution of state laws offering medical exemptions
occurred.5 In addition, at least seventeen states also authorize exemptions
based on "philosophical" beliefs. 6 However, as parents regularly use
exemptions from school vaccination policies based on moral,
philosophical, or personal grounds, such exemptions present difficult
challenges to the enforcement and effectiveness of mandatory vaccination
as a prerequisite to school enrollment.57 In most states, if a required
vaccination has not been obtained and there is no health condition or
religious objection preventing immunization, the child must receive the
vaccinations before school entry. 8 In making these types of decisions,
46. FuRRow, supra note 45.
47. Id.
48. Id.
49. Jacobson v. Massachusetts, 197 U.S. 11 (1905).
50. Silverman, supra note 44, at 280.
51. CDC, National Vaccine Program Office, Immunization Laws, http://www.
hhs.gov/nvpo/law.htm (last visited Sept. 5, 2007).
52. Id.
53. Id.
54. Silverman, supra note 44, at 282.
55. Id.
56. Id. at 284.
57. Id.
58. CDC, supra note 51.
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courts have historically relied upon the fact that the huge reductions in
morbidity and mortality rates, as seen in the past with diphtheria, pertussis,
and polio immunizations, are considered among the most significant
achievements in public health59 and have generally justified mass
inoculation. Accordingly, the preliminary data on the HPV vaccine
indicates that it too will be a potent defense against a killer disease.
IV. CURRENT STATUS AND PROGRESS OF MANDATORY
HPV VACCINATION LAWS - STATE ACTION
The fight over the Gardasil vaccination has escalated into the political
arena, where state officials and legislators are wrestling with social
concerns raised by the vaccine.60 Legislatures in at least forty-one states
and the District of Columbia have initiated legislation to require, fund, or
educate the public about the HPV vaccine. At least seventeen states have
enacted this legislation.6' In September 2006, the Michigan Senate was the
first to introduce legislation (S.B. 1416) to require the HPV vaccine for
girls entering sixth grade, but the bill was not enacted.62 Ohio also
considered legislation in 2006 to require the vaccine (H.B. 703), but this
effort failed as well.63
To date, the fiercest battle over Gardasil has taken place in Texas.64 On
February 2, 2007, Texas became the first state to enact a mandate - by
executive order from the governor - that all females (aged eleven and
twelve) entering the sixth grade receive the vaccine, with a few
65
exceptions. The Texas mandate allowed parents to opt out of the
vaccination by filing an affidavit objecting to it on religious or
philosophical grounds.66 Texas Governor, Rick Perry, also directed state
health authorities to make the vaccine available at no cost to girls between
the ages of nine and eighteen who are uninsured or whose insurance does
not cover vaccination. 67 In addition, the governor ordered that Medicaid
offer Gardasil to women between the ages of nineteen and twenty-one.
68
The governor attempted to sidestep opposition in the state legislature from
59. Silverman, supra note 44. See generally CDC, supra note 44.
60. Joshua Slatko, Controversy Over Gardasil, 26(5) MED AD NEWS, May 1, 2007,
at 46, available at LEXIS.
61. NAT'L CONFERENCE OF STATE LEGISLATURES, supra note 8. The seventeen states
that have enacted this legislation include Colorado, Indiana, Iowa, Maine, Maryland,
Minnesota, Nevada, New Mexico, New York, North Carolina, North Dakota, Rhode Island,
South Dakota, Texas, Utah, Virginia and Washington.
62. Id.
63. Id.
64. Slatko, supra note 60.
65. NAT'L CONFERENCE OF STATE LEGISLATURES, supra note 8.
66. Associated Press, MSNBC.com, Texas Governor Orders STD Vaccine For All
Girls, Feb. 3, 2007, http://www.msnbc.msn.com/id/16948093/wid/ 11915773/.
67. Id.
68. Id.
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conservatives and parents' rights groups by employing an executive order
to implement the law. 69  Many felt that this specific Texas law was
motivated by profit, as it had been reported and speculated that the
governor had ties to both Merck and Women in Government, an advocacy
group composed of female state legislators around the country. 7
Furthermore, reacting to the Texas law, a group of families filed a lawsuit
seeking to block the governor's executive order by claiming that he went
beyond his authority and illegally issued the order.7' As a result of the
debate surrounding the bill, legislators in Texas immediately and
vehemently passed H.B. 1098, overriding the executive order. The
governor withheld his veto.72
A similar dispute has arisen in Florida, where the proposed legislation
would require all 11- and 12-year-old girls to be inoculated with the HPV
vaccination beginning in the year 2009. 73 As of March 2007, however, this
legislation also appears stymied as the debate regarding the vaccine's
safety and social policy implications continues.
74
In March of 2007, despite the controversy surrounding the Texas and
Florida bills, the Virginia legislature passed a school vaccine requirement
mandating the HPV vaccination for girls entering the sixth grade beginning
in October of 2008. 75 To quash any opposition, Virginia's governor sent
an amendment back to the legislature that gave parents more exemption
rights.76 The legislature approved the amendments and the bill was signed
into law, making Virginia the only state with a school requirement for the
vaccine. 77 So far, as of 2007, at least twenty-four states and the District of
Columbia have introduced legislation to specifically mandate the HPV
vaccine for schools.
78
Merck has also received heavy criticism for its involvement in
lobbying for state-mandated vaccinations with Gardasil like the one in
Texas.79 More specifically, opponents to the vaccine have used Merck's
perceived financial incentives as a weapon in fighting the drug's use.
Opponents have cited similar situations in which two vaccines for
69. Associated Press, supra note 66.
70. Id. See also Associated Press, FoxNews.com, Merck Lobbies for HPV
Vaccination to Become Law, Jan. 30, 2007, http://www.foxnews.com/story/
0,2933,248781,00.html.
71. Perry is Sued Over HPV Vaccine Order, HOUSTON CHRON., Feb. 24, 2007, at B4,
available at http://chron.com/CDA/archives/archive.mpl?id=2007_4292335.
72. NATIONAL CONFERENCE OF STATE LEGISLATURES, supra note 8.
73. Slatko, supra note 60.
74. Id.
75. Editorial, Too Many Questions: Virginia Should Reconsider Mandating HPV
Vaccine, DAILY PRESS (Newport, VA), June 21, 2007, (Commentary), available at LEXIS.
76. NAT'L CONFERENCE OF STATE LEGISLATURES, supra note 8.
77. Id.
78. Id.
79. Slatko, supra note 60.
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adolescents that were approved in recent years - for meningitis and
whooping cough - have still not yet been mandated in Texas.8°  In
addition, the chicken pox vaccine that was approved approximately ten
years ago remained on the market for several years before public health
officials pushed to make it mandatory. 81 In response, proponents of the
HPV vaccine note that the incidence of chicken pox, whooping cough, and
meningitis is in no way analogous to the alarming rates of cervical cancer.
In the case of HPV, the sense of urgency to mandate the vaccination stems
from the need to eliminate the disease.
As a result of the uproar surrounding the push for legislation mandating
the vaccine for young girls, many states, such as California, have added
additional amendments to their bills allowing for more flexibility and
further consideration.82 There has also been a push from California
legislators to produce a brochure about the vaccine.83 Furthermore, in
response to the criticisms, Merck announced that it would stop lobbying
state legislatures to require the use of its new cervical cancer vaccination.
84
The company made the decision after realizing that its lobbying campaign
had fueled objections across the country - including considerable furor
from parents, advocacy groups, and public health experts - that could
undermine adoption of the vaccine. 85 However, Merck will continue to
provide health officials and legislators with educational information about
the vaccination and lobby for more financing for vaccines in general.86
V. ARGUMENTS AGAINST MAKING THE HPV
VACCINATION MANDATORY
Although recent evidence has demonstrated that prophylactic vaccines
are well-tolerated and effective in preventing persistent HPV infection,87
the vaccine has not uniformly demonstrated clinical efficacy. 88 Moreover,
80. Stephanie Saul & Andrew Pollack, Furor on Rush to Require Cervical Cancer
Vaccine, N.Y. TIMES, Feb. 17, 2007, available at http://www.nytimes.com/2007/02/17/
health/i7vaccine.htrnl?ex=l 173502800&en=Oddcc09dad50cc000&ei=5070.
81. Joel Elliot, Resignation Cites Pressure to OK HPV Vaccination, MORNING
SENTINEL (Waterville, ME), Mar. 3, 2007, available at http://morningsentinel.mainetoday.
com/news/ local/3675252.html.
82. Fred Ortega, Experts Gather to Tout Vaccine, SAN GABRIELVALLEY TRIBUNE
(Cal.), May 19, 2007.
83. CNN.corn, Lawmakers Want Brochure About Cancer Vaccine Created, Feb. 16,
2007 (on file with author).
84. Andrew Pollack & Stephanie Saul, Lobbying For Vaccine to be Halted, N.Y.
TIMES, Feb. 21, 2007, at Cl, available at http://www.nytimes.com/2007/02/2l/business/
21 merck.html?ex= 1329714000&en=a 1 e44a0345d69131 &ei=5090&partner=rssuserland&e
mc=rss.
85. Id.
86. Id.
87. Jessica A. Kahn & David I. Bernstein, Human Papillomavirus Vaccines and
Adolescents, 17(5) CURRENT OPINION OBSTETRICS GYNECOLOGY 476, 476 (2005).
88. Id.
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questions remain regarding the long-term health risks associated with the
HPV vaccine, the duration of protection, overall vaccine acceptability, and
the cost and feasibility of vaccine delivery.
89
One of the most pressing concerns regarding mandating the HPV
vaccination for schoolgirls is the potential health risks associated with the
vaccine. In the studies conducted so far, women were followed for only
five years, which leaves questions regarding the long-term effects of the
drug unanswered. 90 There is worry that the vaccine has not been on the
market long enough to give any indication of its long-term safety 91 and that
potential side effects of Gardasil might have been overlooked in order to
rush the drug to the market and increase profits.92 Many are concerned that
Gardasil will mimic the path of another well-known drug, Vioxx, a
painkiller, which was taken off the market in 2004. Vioxx was withdrawn
after evidence was discovered that it increased the risk of heart attack, a
hazard which was uncovered early on in testing but was ultimately ignored
in order to quickly release the painkiller to the market. 93  Although
researchers may not be able to predict with certainty the long-term safety of
Gardasil, the five years of safety data in existence includes no signs of
long-term risks or decreased effectiveness. 94  Furthermore, at present,
federal regulators conclude that these potential side effects are insufficient
to offset Gardasil's benefits.95
Other critics point out that HPV, unlike measles or chicken pox, cannot
be transmitted through casual contact, as HPV is a sexually transmitted
96disease. The question therefore becomes whether states should mandate
medical intervention for diseases that are not easily communicable during
casual day-to-day contact. The vaccine does not prevent a "childhood"
disease, but prevents a disease which may lay dormant for many years and
89. Kahn & Bernstein, supra note 87.
90. CBS Evening News: Should HPV Vaccine Be Mandatory? (CBS television
broadcast Jan. 20, 2007), http://www.cbsnews.com/stories/2007/01/20/eveningnews/
main2381159.shtml). However, study results as of June 2007 suggest that the efficacy of
Gardasil (HPV types 6, 11, 16, 18 vaccine) will be long-lasting. In women who had been
vaccinated with Gardasil five years before, robust immunity memory was observed when
they were re-exposed to the vaccine HPV types. See Gardasil Induces Robust Immune
Response Against HPV Five Years After First Dose, CANCER DRUG NEWS
PHARMACEUTICALS (Espicom Bus. Intelligence Ltd.), June 28, 2007.
91. Jane Brody, HPV Vaccine: Few Risks, Many Benefits, N.Y. TIMES, May 15,
2007, available at http://www.nytimes.com/2007/05/1 5/health/i 5brod.html?ex=
1336881600&en=a245fcdd23d0d5ae&ei=5088&partner=rssnyt&emc=rss.
92. Paul Gullixson, No: Families and Doctors Should Call the Shots; HPV Vaccine
is a Great Thing, But Should it be Mandatory?, PRESS DEMOCRAT (Santa Rosa, Cal.), Feb.
18, 2007, at B11.
93. Id.
94. Brody, supra note 91.
95. Slatko, supra note 60.
96. Judy Peres & Bruce Japsen, States Craft HPV Vaccine Bills, CHI. TRIB., Feb. 11,
2007, available at http://www.chicagotribune.com/news/opinion/chi-0702060141 feb06,
1,6626975.story?coll=chi-opinionfront-hed.
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then later strike and kill in the peak of life. It should be emphasized that
mandated vaccinations have not always been limited to airborne
communicable diseases.97 In 1994, New York law was amended to add
Hepatitis B to the list of New York state vaccination requirements.
98Hepatitis B, like HPV, is largely a sexually transmitted disease.
Similarly, the tetanus vaccination is mandated, even though it is transmitted
by wound contamination, not person-to-person contact. 99
Although estimates indicate that the vaccine has the potential to help
prevent the approximated 4,000 deaths and 10,000 diagnoses related to
cervical cancer in the United States each year,100 the price of the
vaccination remains a large concern. In the United States, nearly $3 billion
is spent each year on HPV-related treatment, mostly involving monitoring
and removal of precancerous cervical changes. 1 1  Furthermore, the
vaccine, administered as a series of three shots, costs approximately $120
per dose.10 2 The cost alone may put the vaccine out of reach for many
uninsured women in the United States (as well as those whose insurance
companies balk at the cost), not to mention the millions of poor women
living in the developing world, where cervical cancer is a leading cause of
death.10 3  A study published in the July 2007 issue of the Journal of
Obstetrics & Gynecology found that women and girls from families with
incomes below the poverty line have twice as high a rate of infection with
the HPV types that may cause cancer (22.7 percent) when compared to
women living at least three times above the poverty line (11.7 percent). 10 4
Vaccine advocates are well aware of this concern and have been working
hard to implement programs to make the vaccine widely available to all
people regardless of their insurance plan. In an attempt to circumvent the
cost of the vaccine, as of May 2007, a small number of states including
New Hampshire, Washington, and South Dakota have set up free or funded
Gardasil vaccination programs. 0 5  For example, the Washington state
legislature approved spending $10 million to voluntarily vaccinate 94,000
girls over the next two years. 0 6 In addition, the FDA's pending approval
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101. Marie McCullough, Cost Issues Limit Access to HPV Vaccine, WASH. POST,
January 28, 2007, at A14, available at Women's Cancer Network, http://www.
wcn.org/interior.cfm?featureid=7&id=2005.
102. Brody, supra note 91.
103. Christine Gorman, A Shot Against Cancer, TIME, June 11, 2006, at 66,
available at http://www.time.com/time/magazine/article/0,9171,1202935,00.html.
104. Cancer Vaccines; Poorer Women & Girls Have Higher Risk of Cancer from
Human Papillomavirus (HPV), According to New Cincinnati Children's Study, DISEASE
RISK FACTOR WK., July 22, 2007, at 45.
105. NAT'L CONFERENCE OF STATE LEGISLATURES, supra note 8.
106. Id.
Winter 2008]
and introduction of the second HPV vaccine, Cervarix, should also help to
reduce the cost of the vaccine through competition. Regardless of the
means used to make the vaccine accessible, it is clear that the cost of
preventing cervical cancer by HPV vaccination is far more economically
sound than is the cost (both in dollars and in human suffering) of treating
an advanced case of cervical cancer.
Fear of governmental conspiracies has also caused much concern about
the vaccine. A simple search on the Internet reveals a marked degree of
anxiety and misinformation regarding the HPV vaccine. Some assert that
the vaccine is "poison" while others deem it to be just another "intrusion of
the government" ("the drug pusher") at the request of pharmaceutical
lobbyists "in an effort to make money."'' 0 7 It is obvious that many people
are confused and misled by falsehoods surrounding the HPV vaccine. In
response, the CDC, the WHO, and other organizations have joined together
to refute several myths about vaccinations that sometimes frighten parents
into seeking exemptions.' 
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Lastly, many parents adopt the mentality that the safest possible course
of action is to assure that everyone else's child is vaccinated, and yet not
have their own child vaccinated. Parents reason that if everyone else is
immunized, there is no chance that their child will be subject to the disease,
even if he or she is not immunized. 109 However, public health experts say
that vaccines generally work best when everyone gets them: The laws of
herd immunity dictate that the more people are protected against a
particular virus, the more likely it will eventually disappear altogether.
110
VI. ARGUMENTS IN FAVOR OF MANDATORY HPV
VACCINATION
It is estimated that twenty million Americans are already infected with
HPV, and 6.2 percent of girls between the ages of fifteen and nineteen
become infected each year."' More than six million new HPV infections
occur annually, with 74 percent of the infections occurring in people ages
fifteen to twenty-four. 12 In the United States, close to 4000 women die
annually from cervical cancer.' 3 It is ironic that although science has
created a miraculous vaccine which prevents women from contracting the
most common strains of cancer-causing HPV, policymakers are actually
still questioning whether the vaccine should be mandatory or optional.' "4
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There are many arguments in favor of making the HPV vaccination
mandatory. The facts are clear: The vaccine saves lives. This is the first
vaccine created to remedy cancer - one of the deadliest illnesses affecting
the human population today. This vaccine can be classified as one of the
greatest discoveries in women's health. It has the potential to eventually
eliminate cervical cancer as a cause of death if it is made mandatory." 5
Public health history has shown that without an incentive, such as the threat
of not being admitted into school unless vaccinated, the vaccine will not be
as effective. According to the Centers for Disease Control, approximately
40 percent of children under the age of two do not receive recommended
vaccinations, despite the advice of doctors and aggressive public health
programs. However, by the age of five, when children must show proof of
immunization in order to enroll in public school, there is a 95 percent
compliance rate. (The 5 percent of families who do not comply have
signed waivers exempting their children from being vaccinated, which
would be an option for those opposed to the [HPV] vaccination.)" 16
Making HPV vaccination mandatory is especially important for
adolescents who, for maximum efficacy, need to be vaccinated before the
age at which exposure is likely to occur. In the United States, according to
national survey data, 24 percent of females report being sexually active by
the age of fifteen, 40 percent by the age of sixteen, and 70 percent by the
age of eighteen." 17 Seven percent of high school students (male and female)
reported engaging in intercourse before the age of thirteen, and 10 percent
of sexually active ninth graders reported having had four or more sexual
partners." 18 HPV is easy to contract, hard to detect, and transmission often
occurs soon after sexual debut." 9 In one study, 39 percent of college-aged
women acquired HPV within twenty-four months of onset of sexual
activity. 120  Furthermore, in a study of adolescents and young women
between the ages of thirteen to twenty-one, 70 percent exhibited symptoms
of HPV infection within five to seven years of the onset of sexual
intercourse. 1  The above statistics demonstrate the alarming prevalence
and the almost effortless transmission of the disease. It is important to
recognize that epidemiological studies can only underestimate the true
exposure to HPV infections in light of the fact that short-term infections
will likely go undetected. 122 HPV infections are further underestimated as a
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result of testing and sampling errors that have been demonstrated in studies
using weekly repeated HPV measurements. 123 Thus, it is apparent that
from a public health perspective, routine vaccination at an early age is
imperative to achieve optimal effectiveness, protection, and prevention of
cervical cancer.
Opponents of the vaccine worry that "giving the HPV vaccine to young
women could potentially be harmful, because they may see it as a license to
engage in premarital sex."1 24 There are also concerns that the vaccine will
promote false confidence since the vaccine does not protect against all
strains of HPV or many other sexually transmitted diseases. 125 However,
evidence has shown no link between the vaccine and an increase in sexual
activity. According to a study led by the University of North Carolina at
Chapel Hill, adolescent girls vaccinated against HPV were not likely to
engage in sex more often than adolescent girls who were not vaccinated.1
26
Furthermore, a 2007 Cochrane Library review found that girls given Plan B
emergency birth control pills to have "just in case" were not any more
likely to engage in sex than those who were not given the pills. 127 As
Washington, D.C., Councilman David Catania, who sponsors the
mandatory vaccination bill, stated, "the legislation doesn't require that the
conversation about the vaccine, center on why you are receiving the
vaccine.., this vaccine no more encourages sexual activity than a tetanus
shot encourages you to step on a rusty nail."'
128
In reality, the awkward "birds and the bees" talk between parents and
their children is often ignored because parents do not want to acknowledge
the mere thought that their child will ever become sexually active,
especially at a young age. Without mandating the vaccination, it is likely
that parents will continue to ignore this reality until their child becomes
sexually active and is exposed to the virus. What do parents say to their
daughter when she comes home from college and informs them that she has
HPV, a disease that they could have prevented through vaccination? 129 If
the decision is left up to the children once they leave the family home, they
are less likely to be vaccinated. Children feel invincible as they get older
and seek out reactive medical care for a problem - not preventative
measures. While it may be a parent's right and responsibility to make
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decisions for their minor child, history reveals that the public has
frequently intervened to protect the welfare of children when parents are
inattentive to their parenting duties, such as in cases of abuse and
neglect.' 30 It is important to remember the main reason for the vaccination:
To prevent cancer. Therefore, if parents are hesitant to discuss sexual
matters with their children, then they can truthfully explain that the HPV
vaccine protects against a type of cancer.
The most crucial argument in support of making the HPV vaccination
mandatory is the fact that infection can be transmitted by engaging in
"foreplay" alone, not just sexual intercourse.' 31 Sexual contact is not
necessary for the transmission of cancer-causing HPV.132 In one study, 7.8
percent of virginal females developed infection through nonpenetrative
sexual practices. 133 HPV has been found in saliva as well as the mucus of
the genital tract, urine, and semen. 134  Cancer-causing HPV strains,
including strains 16 and 18, have also been found on the skin of the hands
and fingers. 35 In fact, squamous cell carcinoma of the finger is almost
exclusively caused by HPV strains 16 and 18, the same cause of 70 percent
of cervical cancer. 136  HPV is spread through skin-to-skin contact, so
condoms will not always protect against it, which translates to "there is no
such thing as safe sex" or "safe foreplay."' 37 In other words, abstinence
will not guarantee protection from developing cervical cancer. 38  Too
often, young girls will engage in what they perceive to be "safe" foreplay
only to discover years later that they have HPV, or even worse, cervical
cancer.
A long and bitter battle over sex education has raged in this country
between religious conservatives and virtually every major medical
organization. Religious groups, arguing that sex outside of wedlock is
unholy, have secured millions of federal dollars for abstinence programs
that teach about the hazards of contraceptives. 39 These groups, who are
also opposed to the idea of mandating the vaccine for girls in middle
school, are concerned that mandating the vaccine would be "forcing"
therapy onto healthy girls with the opinion that future sexual behavior
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131. Grimshaw-Mulcahy, supra note 32, at 13.
132. Wendy Anne Epstein, HPV Vaccine: It's Not About Sex, It's About Cancer
Prevention, J. NEWS (Westchester County, N.Y.), May 26, 2007 at 4B.
133. Grimshaw-Mulcahy, supra note 32, at 13.
134. Cancer Vaccines; HPV Infection Linked to Throat Cancers, SCi. LETTER, May
22, 2007, at 244.
135. Epstein, supra note 132.
136. Id.
137. Jodie Morse, An Rx For Teen Sex, TIME, Oct. 7, 2002, at 64, available at
http://www.time.com/time/magazine/article/0,9171,1003380,00.html.
138. Epstein, supra note 132.
139. Morse, supra note 137.
Winter 2008]
HASTINGS WOMEN'S LAW JOURNAL
might result in a disease. 40  However, in response, this is the precise
principle that has laid the foundation for every immunization program. 14'
A glimpse into the history of immunization clearly indicates that the entire
population did not contract measles, polio, or smallpox before the
introduction of mandatory vaccines to protect every child.142 Furthermore,
history has revealed that the population tends to avoid vaccinations unless
they are required. According to Dr. Louis Cooper, a past president of the
American Academy of Pediatrics, "mandates provide a reminder ... when
several new vaccines came online in the 1950s and '60s, including vaccines
for polio, measles, mumps and rubella, disease rates did not decline
significantly unless states started requiring vaccination for school
enrollment."'
143
Parents and religious groups commonly criticize the HPV vaccine,
making the argument that abstinence, not vaccination, is a better way to
prevent the spread of sexually transmitted diseases. "But the abstinence
message is rarely effective. Half of all girls become sexually active before
graduating from high school. 14 4 Moreover, for some (as in molestation
and abuse cases), sexual behavior occurs against their will.145 Government
data shows that 70 percent of girls have had intercourse by age eighteen. 146
In 2002, HPV was estimated to infect more than 15 percent of sexually
active teens. 14 7 That estimate has drastically increased over the past five
years. The risk of exposure to carcinogenic and noncarcinogenic HPV
types increases with the number of sex partners a person has in a
lifetime. 148 HPV-related statistics clearly indicate that in order to provide
complete protection from the infection before the onset of sexual activity,
immunization prior to middle school will be most beneficial. 49 Equally
important is that even if a child remains totally virtuous and abstinent until
her wedding night, there is no guarantee her new husband or partner has
remained equally chaste and will not infect her with HPV, leading later to a
difficult and painful battle with cervical cancer. 150 In essence, moral values
are no protection from the virus. Furthermore, by making immunization
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mandatory, much of the social pressure is removed from the parent and the
injections are more easily explained to the child. If the child inquires about
the vaccine, the parent can simply say that it is mandated by the state.
In further support of the push for wide use of the vaccine, it has been
recently discovered that the HPV vaccination may protect against other
types of cancer including vaginal, anogenital,' 51 and throat cancers. The
cancer-causing HPV strains 16 and 18 have been linked to several other
forms of cancer in both sexes including mouth, esophagus, larynx, tongue,
tonsils, rectum, uncircumcised penis, and skin.152 According to a May
2007 study in the New England Journal of Medicine, researchers at the
Johns Hopkins University confirmed that infection with HPV through oral
sex is the leading cause of throat cancer, which strikes 11,000 American
men and women each year. 153 The study involved 100 people with throat
cancer and 200 without it and found that those infected with HPV were
thirty-two times more prone to develop a type of oral cancer than those free
of the virus.154 Experts say that the "findings could help explain why rates
of oral cancer have been increasing in recent years, particularly among
younger people who are not smokers or heavy drinkers, which had long
been the primary risk groups."'155 Many adolescents also report that they
often opt to engage in oral sex as a less risky type of sex. 156 These findings
and reports further support the argument for advocating mandatory
vaccinations for school-aged girls.
The link between HPV and throat cancer also provides additional
ammunition for advocates who urge that boys too should be immunized
because they can spread the sexually transmitted infection to women.
57
While HPV-linked cervical cancer is gender-specific, researchers believe
that men may benefit from this vaccine as HPV is also a major cause of
anal cancer and genital warts, which can affect either sex.' 58  Also,
vaccinating males might help the female population even more than the
male population because even though the sexes contract the virus at the
same rate, females get 95 percent of the diseases it causes. 59 Although in
the Unites States studies are still ongoing regarding the use of the vaccine
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in the male population, Australia and the European Union have approved
the vaccine for both sexes.
160
Making the HPV vaccine mandatory essentially makes it accessible.
Many people will not have access to the vaccine and parents might not
know to ask for it or be able to afford it unless it is mandatory. 61 If it is
available in theory but the price tag is too high, it is not available to
everybody.162 Lawmakers have said that their motivation in supporting
mandatory HPV vaccination is to ensure widespread inoculation and to
erase economic disparities in cervical cancer, which is most common
among low-income women who are also the least likely to have Pap smear
screenings. 163 Studies have clearly demonstrated that when mandates are in
place, racial and economic disparities in disease contraction among those
vaccinated virtually disappear.' 
64
Tests show that HPV-induced, precancerous conditions that require
expensive medical attention could be avoided with vaccination.
65
Therefore, if vaccination is mandated, there are strong arguments that it
will help cut health costs across the nation and around the globe. In
response to the objections raised regarding the high price-tag on the
vaccine, HPV infections are far more costly. Research suggests that the
HPV vaccine has the potential to reduce the substantial morbidity and
mortality associated with cervical cancer and other HPV-associated
diseases. 166 Implementation of both prophylactic and therapeutic vaccine
regimens could cause a considerable reduction in healthcare costs and in
the incidence of cervical cancer worldwide. 67 According to the American
Journal of Obstetrics and Gynecology, "the annual burden of cervical
HPV-related diseases ranged from $2.25 billion to $4.6 billion in the
United States. The annual burden of cervical cancer ranges from $181.5
million to $363 million.' 68 Hence, the HPV vaccine is likely to prevent
the need for biopsies, colposcopies, and other costly medical procedures
associated with the diagnosis and treatment of cervical cancer and genital
warts.
In June 2006, the Gates Foundation announced that it would spend $28
million over the next five years to determine whether a cervical cancer
vaccine can be made more widely available. 169 Additionally, the National
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Conference of State Legislatures reports that at least thirty-one states are
deliberating bills that would require vaccination, funding for vaccinations,
and/or the distribution of information about HPV. 17 ° Furthermore, on the
basis of the CDC's decision and recommendations from other professional
organizations to administer the vaccine prior to sexual activity, it is highly
likely that the federal Vaccines for Children Program - which provides
free shots to eligible children, uninsured individuals, and uninsured
families - as well as other private insurers will provide Gardasil to school-
aged children at no charge. 171 Researchers believe that these types of
programs should be sufficient to assure widespread distribution of the
vaccine.
VII. PROPOSAL AND CONCLUSION
One in four American women aged fourteen to fifty-nine is infected
with a sexually transmitted virus that in some forms can cause cervical
cancer, according to the first extensive national estimate. 7 ' This year
alone, an estimated 11,150 American women will be diagnosed with
cervical cancer. 73 Prevention is the key in the case of HPV. Preventing
the spread and incidence of any disease, especially a disease such as
cervical cancer that has the capacity to go undetected and kill millions, is
constructive. In order to be protected from the cancer-causing strains of
HPV, a woman must be immunized at a young age prior to exposure.
In most of the United States, parents have the right to exemptions from
mandatory vaccination programs based on religious and/or philosophical
grounds. 174  As more parents take advantage of exemption provisions,
frequently because of misinformation, the childhood vaccination exemption
rates will continue to skyrocket. As a result, practical and collaborative
solutions are needed to ensure significant protection of the public health.
As promoted by many advocates, the goal should not be to eliminate the
ability to seek an exemption, since such an action would "exacerbate
feelings of animosity and skepticism toward vaccination and the public
health system in general.' 75 Instead, the goal should be to improve public
awareness of the benefits and isolated risks of HPV vaccination, as well as
the public health risk caused to and by those who refuse vaccination. 176
According to a Wall Street Journal Health Care poll, 42 percent of the
population had not even heard of HPV even though a large majority (70
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percent) reacted favorably in the same poll to the use of the vaccine to
prevent it. 177 Greater public education is obviously needed. Improving
public knowledge about the vaccine could be established by instituting
mandatory information sessions for parents who seek exemption prior to
one being granted. This system has been referred to as an "informed
refusal" process.178 Before receiving an exemption, applicants would meet
with a health professional, such as a school nurse or primary care provider,
to discuss the potential risks and benefits of immunization and
exemption. 179 This process would help dispel many of the myths and
misinformation that deter parents from having their children vaccinated.
Additionally, improvements could be made in the knowledge of health care
professionals, school officials, and especially nurses, regarding application
of state exemption laws. 180  At the least, states should implement a
voluntary HPV vaccination program (such as New Hampshire's program)
which includes a strong educational component. For example, the New
Hampshire Health Department announced in 2006 that it would be
providing the vaccine at no cost to girls under the age of eighteen. 8 As of
May 2007, the department reports that they have distributed over 14,000
doses in the state.
1 82
Even if the nation is currently not ready for the vaccine to be mandated
at schools, it is the hope that it will be in the near future. The solution to
decreasing HPV rates and cervical cancer is to guarantee universal access
by all women through prevention strategies such as HPV vaccination,
regular gynecological care, and Pap testing. The HPV vaccine needs to be
used widely to be protective at a population level. In other words, when
dealing with HPV, the best offense is a good defense - the HPV
vaccination. It is apparent that the public desires further information
regarding the long-term safety and effectiveness of the vaccine before it is
willing to accept and implement a law requiring blanket vaccination as a
prerequisite to entering school. However, if all females are vaccinated, the
virus will eventually have no way to spread and it is likely that cervical
cancer will be eliminated in the United States.1 83 As stated by Ann DuBay,
"[t]here is no greater gift the public health system could give to their
daughters."184
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